Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nilotinib”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Testing effectiveness (Phase 2)Study completedNCT01166139
What this trial is testing

Nilotinib in the Treatment of Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 10
Testing effectiveness (Phase 2)Study completedNCT01806571
What this trial is testing

Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Untreated Adult Acute Myeloid Leukemia
Mayo Clinic 34
Not applicableStudy completedNCT03885830
What this trial is testing

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Who this might be right for
CML, Chronic PhaseCML (Chronic Myelogenous LeukemiaCML - Philadelphia Chromosome+2 more
UNC Lineberger Comprehensive Cancer Center 45
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Study completedNCT00788775
What this trial is testing

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

Who this might be right for
Mucosal Lentiginous MelanomaAcral MelanomaMelanoma
Dana-Farber Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT00760877
What this trial is testing

Nilotinib Versus Standard Imatinib (400/600 mg Every Day (QD)) Comparing the Kinetics of Complete Molecular Response for Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) Pts With Evidence of Persistent Leukemia by Real-time Quantitative Polymerase Chain Reaction (RQ-PCR)

Who this might be right for
CHRONIC MYELOGENOUS LEUKEMIA
Novartis Pharmaceuticals 207
Testing effectiveness (Phase 2)Study completedNCT00769327
What this trial is testing

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 129
Large-scale testing (Phase 3)Ended earlyNCT03079505
What this trial is testing

Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia - Chronic Phase
Hamad Medical Corporation 10
Large-scale testing (Phase 3)UnknownNCT03942094
What this trial is testing

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia, Chronic PhaseNilotinib
Shenzhen Second People's Hospital 100
Post-approval studies (Phase 4)Study completedNCT01368523
What this trial is testing

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 19
Not applicableStudy completedNCT02363868
What this trial is testing

Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population

Who this might be right for
Chronic Myeloid Leukemia (CML)
Bristol-Myers Squibb 186
Testing effectiveness (Phase 2)Study completedNCT00762632
What this trial is testing

Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Technical University of Munich 40
Not applicableUnknownNCT04739826
What this trial is testing

Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
CML, Chronic Phase; TKI
The First Affiliated Hospital of Soochow University 491
Testing effectiveness (Phase 2)Study completedNCT01395121
What this trial is testing

A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread

Who this might be right for
Mucosal Lentiginous MelanomaAcral Lentiginous Malignant Melanoma
Institute of Cancer Research, United Kingdom 29
Testing effectiveness (Phase 2)Study completedNCT03932669
What this trial is testing

Effect of Nilotinib in Cerebellar Ataxia Patients

Who this might be right for
Ataxia, CerebellarAtaxia, Progressive
Seoul National University Hospital 70
Early research (Phase 1)Looking for participantsNCT04903119
What this trial is testing

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

Who this might be right for
Metastatic MelanomaBRAF Gene Mutation
Rina Plattner 30
Early research (Phase 1)Study completedNCT00732888
What this trial is testing

Effect of Calcium on Tasigna Pharmacokinetics (PK) in Healthy Volunteers

Who this might be right for
Healthy
Jan Beumer 14
Large-scale testing (Phase 3)Ended earlyNCT02108951
What this trial is testing

Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors.

Who this might be right for
Philidelphia Positive Chronic Myeloid Leukaemia
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT02709083
What this trial is testing

Dasatinib or Nilotinib Followed by Imatinib in Patients With Newly Diagnosed, Chronic Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous LeukemiaChronic Myeloid LeukemiaLeukemia
Emory University 7
Not applicableStudy completedNCT01370980
What this trial is testing

Collaborative Seamless Care in Oncology : Measure and Reinforce Safety and Adherence to Oral Cancer Treatment

Who this might be right for
Cancer
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland 43
Next Page